Total Payments
$730,976
2024 Payments
$54,194
Companies
63
Transactions
1,593
Medicare Patients
7,757
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$453,941 (62.1%)
Consulting$115,965 (15.9%)
Travel$89,154 (12.2%)
Food & Beverage$36,717 (5.0%)
Royalty/License$21,266 (2.9%)
Research$13,874 (1.9%)
Education$59.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $453,466 | 209 | 62.0% |
| Consulting Fee | $115,965 | 78 | 15.9% |
| Travel and Lodging | $89,154 | 363 | 12.2% |
| Food and Beverage | $36,717 | 928 | 5.0% |
| Royalty or License | $21,266 | 4 | 2.9% |
| Unspecified | $13,874 | 8 | 1.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $475.00 | 1 | 0.1% |
| Education | $59.59 | 2 | 0.0% |
Payments by Type
General
$717,101
1,585 transactions
Research
$13,874
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $408,608 | 645 | $0 (2024) |
| Medtronic USA, Inc. | $180,952 | 280 | $0 (2020) |
| Aurora Spine, Inc. | $46,420 | 10 | $0 (2022) |
| MML US, Inc. | $25,381 | 66 | $0 (2024) |
| Nevro Corp. | $22,974 | 54 | $0 (2023) |
| Abbott Laboratories | $17,012 | 103 | $0 (2024) |
| BIOTRONIK INC. | $4,637 | 9 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $4,559 | 25 | $0 (2023) |
| Depomed, Inc. | $4,236 | 14 | $0 (2017) |
| BIOTRONIK NRO, Inc. | $2,342 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $54,194 | 130 | Medtronic, Inc. ($37,104) |
| 2023 | $70,341 | 205 | Medtronic, Inc. ($54,801) |
| 2022 | $229,016 | 405 | Medtronic, Inc. ($210,547) |
| 2021 | $145,738 | 221 | Medtronic, Inc. ($106,157) |
| 2020 | $104,912 | 155 | Medtronic USA, Inc. ($103,814) |
| 2019 | $66,809 | 199 | Medtronic USA, Inc. ($31,749) |
| 2018 | $37,779 | 128 | Medtronic USA, Inc. ($30,873) |
| 2017 | $22,187 | 150 | Medtronic USA, Inc. ($14,516) |
All Payment Transactions
1,593 individual payment records from CMS Open Payments — Page 1 of 64
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Pain Management | ||||||
| 12/18/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $39.70 | General |
| Category: Pain Management | ||||||
| 12/12/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $20.97 | General |
| Category: Pain Management | ||||||
| 12/05/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/21/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: Pain Management | ||||||
| 11/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,400.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/17/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $98.22 | General |
| Category: Pain Management | ||||||
| 11/15/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $299.04 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/15/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $162.50 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $309.04 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $259.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $104.62 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $57.67 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/13/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $44.52 | General |
| Category: Pain Management | ||||||
| 11/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,325.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/06/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $19.44 | General |
| Category: Pain Management | ||||||
| 11/04/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $181.85 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $85.04 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $32.81 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/01/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $187.85 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/01/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $171.49 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/01/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Travel and Lodging | In-kind items and services | $41.92 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/31/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $71.51 | General |
| Category: Pain Management | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Evoke Study | Saluda Medical Americas, Inc. | $174.38 | 3 |
| ECAP Study | Saluda Medical Americas, Inc. | $100.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,126 | 2,563 | $548,270 | $126,565 |
| 2022 | 23 | 1,738 | 4,977 | $1.2M | $269,613 |
| 2021 | 28 | 2,001 | 5,953 | $1.3M | $297,317 |
| 2020 | 35 | 2,892 | 7,264 | $2.2M | $422,770 |
Total Patients
7,757
Total Services
20,757
Medicare Billing
$1.1M
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 205 | 404 | $106,080 | $35,794 | 33.7% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 90 | 109 | $65,000 | $21,074 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 231 | $41,760 | $14,698 | 35.2% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 217 | 569 | $68,280 | $14,076 | 20.6% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 46 | 53 | $39,220 | $12,825 | 32.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 134 | 171 | $35,910 | $10,353 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $18,440 | $5,646 | 30.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 12 | 13 | $55,340 | $3,421 | 6.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 13 | 14 | $32,300 | $2,294 | 7.1% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 14 | 33 | $29,205 | $2,252 | 7.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 83 | 160 | $17,600 | $1,672 | 9.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 17 | 27 | $8,695 | $1,125 | 12.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 11 | 11 | $26,660 | $1,067 | 4.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 16 | 38 | $2,470 | $88.27 | 3.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 17 | 42 | $504.00 | $70.39 | 14.0% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 40 | 168 | $336.00 | $64.09 | 19.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 39 | 470 | $470.00 | $45.25 | 9.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 329 | 895 | $241,650 | $88,626 | 36.7% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2022 | 373 | 1,289 | $154,680 | $34,738 | 22.5% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 76 | 131 | $96,940 | $31,516 | 32.5% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 89 | 150 | $89,250 | $29,398 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 175 | 359 | $66,415 | $23,741 | 35.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 177 | 323 | $67,830 | $19,702 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $25,370 | $6,995 | 27.6% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 33 | 42 | $21,840 | $6,494 | 29.7% |
About Dr. Michael Fishman, MD
Dr. Michael Fishman, MD is a Pain Medicine healthcare provider based in Lebanon, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1841429156.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Fishman, MD has received a total of $730,976 in payments from pharmaceutical and medical device companies, with $54,194 received in 2024. These payments were reported across 1,593 transactions from 63 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($453,466).
As a Medicare-enrolled provider, Fishman has provided services to 7,757 Medicare beneficiaries, totaling 20,757 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine, Pain Medicine
- Location Lebanon, PA
- Active Since 07/08/2009
- Last Updated 10/24/2024
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841429156
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $236,511
- INTELLIS (Device) $158,617
- ZIP (Device) $46,420
- VANTA ADAPTIVESTIM (Device) $40,988
- RESTORE (Device) $36,314
- ADAPTIVESTIM (Device) $31,721
- ReActiv8 (Device) $25,381
- Senza Spinal Cord Stimulation System (Device) $22,383
- SYNCHROMED (Device) $11,620
- Proclaim Family of SCS IPGs (Device) $10,674
- Nucynta (Drug) $4,223
- BELBUCA (Drug) $4,170
- Neuromodulation Dspsbls and Accs (Device) $3,096
- OPTIMIZER (Device) $2,709
- RESTORESENSORSURESCAN (Device) $2,573
- Inflate FX (Device) $2,450
- Prospera (Device) $2,146
- Vanta (Device) $1,927
- Intracept (Device) $1,681
- mild Device Kit (Device) $1,646
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Lebanon
Dr. Bert Fichman, Md, MD
Pain Medicine — Payments: $29,709
Pain Medicine $29,709
Dr. Michael Bova, Md, MD
Pain Medicine — Payments: $11,689
Pain Medicine $11,689
Dr. Michael Knox, Md, MD
Pain Medicine — Payments: $8,759
Pain Medicine $8,759
Dr. Robert Knipe, D.o, D.O
Pain Medicine — Payments: $7,850
Pain Medicine $7,850
Thomas Baker, M.d, M.D
Pain Medicine — Payments: $6,459
Pain Medicine $6,459
Ajitpal Grewal, M.d, M.D
Pain Medicine — Payments: $5,735
Pain Medicine $5,735